Study on synthesis and properties of nanoparticles loaded with amaryllidaceous alkaloids

Alzheimer’s disease (AD) is the most common disease among the elderly people and a major social and medical problem. Amaryllidaceous alkaloids, acting as acetylcholinesterase inhibitors, represent a potential treatment of AD. However, they also have some deficiencies, such as extensive toxicity and...

Full description

Saved in:
Bibliographic Details
Published in:Open life sciences 2017-11, Vol.12 (1), p.356-364
Main Authors: Duan, Lihong, Li, Meng, Wang, Chunbao, Wang, Qingmei, Liu, Quanquan, Shang, Wanfeng, Shen, Yajin, Lin, Zhuohua, Sun, Tongyang, Quan, Daping, Wu, Zhengzhi
Format: Article
Language:English
Subjects:
Alzheimer disease
Amaryllidaceous alkaloids
Click chemistry
Low density lipoprotein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer’s disease (AD) is the most common disease among the elderly people and a major social and medical problem. Amaryllidaceous alkaloids, acting as acetylcholinesterase inhibitors, represent a potential treatment of AD. However, they also have some deficiencies, such as extensive toxicity and widespread side effects. In order to improve the bioavailability and reduce the toxic and side effects, brain targeting of amaryllidaceous alkaloids was enhanced by considering low density lipoprotein (LDL) receptors of blood-brain barrier (BBB) endothelial cells as therapeutic targets. Amaryllidaceous alkaloids were highly selectively and quantitatively riveted to the surface of low density lipoproteins by using a new method - mild click chemistry. The structure of products has been characterized by NMR, FT-IR, and other methods. In addition, drug loading rate, encapsulation rate, and drug release by the nanoparticles were determined to assess the quality of the nanoparticles.
ISSN:2391-5412
2391-5412
DOI:10.1515/biol-2017-0041